Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913013 · ClinicalTrials.gov registry record · Phase 1
Technology Enhanced Family Treatment
A Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT03913013 is a Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 65 participants.
The verdict
NCT03913013, a Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
The investigators propose to enhance the scalability of family-focused therapy (FFT), a 12-session evidence-based therapy for youth at high risk for mood disorders, through augmentation with a novel mobile phone application called MyCoachConnect (MCC). In adolescents with mood instability who have a parent with bipolar or major depressive disorder, clinicians in community clinics will conduct FFT sessions (consisting of psychoeducation and family skills training) supplemented by weekly MCC "real time" assessments of moods and family relationships; based on results of these assessments and the family's progress in treatment, clinicians will then push personalized informational and coaching alerts regarding the practice of communication and problem-solving skills. The investigators hypothesize that the augmented version of FFT (FFT-MCC) will be more effective than FFT without coaching/informational alerts in altering treatment targets and in stabilizing youths' mood symptoms and quality of life.
Interventions
- BEHAVIORAL Family-Focused Treatment with MCC App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2021-10-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03913013
The ClinicalTrials.gov registry entry for NCT03913013 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Family-Focused Treatment with MCC App is the first listed.
NCT03913013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03913013 about?
NCT03913013 is a clinical study titled "Technology Enhanced Family Treatment". The investigators propose to enhance the scalability of family-focused therapy (FFT), a 12-session evidence-based therapy for youth at high risk for mood disorders, through augmentation with a novel mobile phone application called MyCoachConnect (MCC). In adolescents with mood instability who have a...
What is the current status of trial NCT03913013?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2018-11-15. Estimated completion is 2021-10-20.
What interventions are being tested in trial NCT03913013?
The interventions under investigation include: Family-Focused Treatment with MCC App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03913013?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.